Cargando…
Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs
Drug dosing in neonates should be based on integrated knowledge concerning the disease to be treated, the physiological characteristics of the neonate, and the pharmacokinetics (PK) and pharmacodynamics (PD) of a given drug. It is critically important that all sources of information be leveraged to...
Autores principales: | Van den Anker, John N., McCune, Susan, Annaert, Pieter, Baer, Gerri R., Mulugeta, Yeruk, Abdelrahman, Ramy, Wu, Kunyi, Krudys, Kevin M., Fisher, Jeffrey, Slikker, William, Chen, Connie, Burckart, Gilbert J., Allegaert, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408157/ https://www.ncbi.nlm.nih.gov/pubmed/32698409 http://dx.doi.org/10.3390/pharmaceutics12070685 |
Ejemplares similares
-
Regulatory Science Needs for Neonates: A Call for Neonatal Community Collaboration and Innovation
por: McCune, Susan K., et al.
Publicado: (2014) -
Creatinine Trends and Patterns in Neonates Undergoing Whole Body Hypothermia: A Systematic Review
por: Borloo, Noor, et al.
Publicado: (2021) -
Rational Use of Antibiotics in Neonates: Still in Search of Tailored Tools
por: van den Anker, John, et al.
Publicado: (2019) -
Dose‐Related Adverse Drug Events in Neonates: Recognition and Assessment
por: Allegaert, Karel, et al.
Publicado: (2021) -
A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates
por: Smits, Anne, et al.
Publicado: (2020)